ÂÜÀòÂÒÂ×

Bénédicte Balland has a diverse work experience beginning in 2003 when they were a Tutor at University Aix-Marseille II. In 2006, they became a Post-Doctoral Fellow at the University of Geneva, Switzerland, researching cellular and molecular mechanisms of addiction. Bénédicte published several papers in journals such as PLoS One (2010), Psychiatrie Science Humaine Neuroscience (PSN, 2009), Neuron (2008), Pediatr Res (2008), Dépendance (revue éditée par l’Institut Suisse de Prévention de l’Alcoolisme et autres toxicomanies, ISPA, 2007), and Science (2007). From 2010 to 2016, they worked as a Patent Engineer Biotechnology at Coralis Harle Phelip. Finally, in 2022, they began their current role as IP Director at Mnemo Therapeutics.

Bénédicte Balland obtained their Master's Degree in 2001-2002 from University Aix-Marseille II, Faculty of Sciences of Luminy, in the field of Cellular Biology and Physiology, Immunologie, Neurosciences. Bénédicte then obtained their DEA (Master2) in 2002-2003 from the same university in Neurosciences. In 2003-2006, they obtained their PhD from University Aix-Marseille II, Faculty of Medicine in Neurosciences. In 2009-2010, they obtained their CEIPI from CEIPI, University Robert Schuman Strasbourg. Bénédicte is currently enrolled in OEB since 2015.